Skip to main content
  • Editorial - MitraClip Real-World Data: What Is Missing and Looking Into the Future

    Bedogni et al. presented the results of the GIse registry Of Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO), confirming that in a real-world setting, functional mitral regurgitation (FMR) was the principal indication to MitraClip (MC) implantation in Italy over degenerative mitral regurgitation (DMR). This is a large registry of about 1200 patients, which included patients [1] in 22 Italian centers between February 2016 and December 2018. Of these, 64.9% were FMR patients, 24.8% were patients with DMR and 10.3% of patients had mixed etiology. The high rate (96.6%) of technical success in GIOTTO was consistent with international registries, such as ACCESS-EU. Many (>50%) patients required at least two clips to reach 87% procedural success, as measured at one month. The authors confirmed that the MC procedure was safe and effective, which is a consistent statement with all previous reports on MC.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details